CVS Health Corp
F:CVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Glodon Co Ltd
SZSE:002410
|
CN |
|
Shandong Sacred Sun Power Sources Co Ltd
SZSE:002580
|
CN |
|
G
|
Goenka Diamond And Jewels Ltd
NSE:GOENKA
|
IN |
|
D
|
Deutsche Eigenheim Union AG
XETRA:JZ6
|
DE |
|
Haci Omer Sabanci Holding AS
IST:SAHOL.E
|
TR |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (13.5), the stock would be worth €63.2 (3% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 14 | €65.38 |
0%
|
| 3-Year Average | 13.5 | €63.2 |
-3%
|
| 5-Year Average | 9.2 | €43.07 |
-34%
|
| Industry Average | 18.7 | €87.54 |
+34%
|
| Country Average | 16.7 | €78.18 |
+20%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
CVS Health Corp
F:CVS
|
98.3B EUR | 14 | 55.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 10.6 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.2 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 12.9 | 19.3 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 11.1 | 23.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 16.4 | 25.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 14.5 | 22.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 6.6 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -66.7 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 10.3 | 13.8 | |
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
8.9B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
CVS Health Corp
Glance View
CVS Health Corporation stands as a pivotal player in the healthcare landscape, tracing its roots back to the early 1960s as a modest chain of health and beauty stores. Evolving through strategic acquisitions and visionary leadership, it burgeoned into one of America’s foremost health solutions providers. The company operates through several segments, each contributing to a comprehensive healthcare ecosystem. Retail/LTC, its retail division, oversees a vast network of pharmacies nationwide, capitalizing on its trusted brand to serve millions of customers with prescriptions, over-the-counter medications, and everyday essentials. Through this extensive reach, CVS leverages its convenience and accessibility, capturing a significant share of consumer healthcare spending. However, CVS's business model doesn't stop at retail. It delves deeper into healthcare through its pharmacy benefits manager, Caremark, which provides employers and insurers with effective cost control for prescription drugs. Additionally, the landmark acquisition of Aetna, a leading health insurer, marked a strategic pivot towards vertically integrated healthcare services. This acquisition has enabled CVS not only to offer insurance products but also to streamline care with initiatives like MinuteClinics and HealthHUBs, aiming to reduce overall healthcare costs while improving patient outcomes. By intertwining its various services, CVS Health positions itself as a pioneer in the industry, standing at the intersection of healthcare delivery, pharmacy services, and insurance management, ultimately crafting synergies that aim to redefine the future of consumer health engagement.